Viewing data from:

TELMISARTAN

ANDA

TELMISARTAN | A207882 | PRINSTON PHARMACEUTICAL INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MICARDIS(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$0.1563

per ea

Lowest NADAC/Unit

$0.1039

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
43547028503TELMISARTAN 80 MG TABLET	$0.1563	EA	Generic	—	2026-08-19
43547028403TELMISARTAN 40 MG TABLET	$0.1536	EA	Generic	—	2026-08-19
43547028303TELMISARTAN 20 MG TABLET	$0.1039	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain28 active DMFs18 inactive

28 active API suppliers hold Drug Master Files for this ingredient.

CIPLA LTDTELMISARTAN USP

DMF 199872006

MATRIX PHARMACORP PRIVATE LTDTELMISARTAN USP

DMF 201092007

ALEMBIC PHARMACEUTICALS LTDTELMISARTAN USP

DMF 202852007

AMINO CHEMICALS LTDTELMISARTAN

DMF 208822007

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDTELMISARTAN USP

DMF 214662007

TAPI NL BVTELMISARTAN

DMF 221232008

ZYDUS LIFESCIENCES LTDTELMISARTAN USP

DMF 226892009

MSN PHARMACHEM PRIVATE LTDTELMISARTAN USP [ROUTE CODE - TM]

DMF 227312009

DR REDDYS LABORATORIES LTDTELMISARTAN (PROCESS-II) USP

DMF 234722010

ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO LTDTELMISARTAN API

DMF 238292010

JUBILANT PHARMOVA LTDTELMISARTAN

DMF 240522010

MACLEODS PHARMACEUTICALS LTDTELMISARTAN

DMF 245642011

TORRENT PHARMACEUTICALS LTDTELMISARTAN USP

DMF 247202011

APITORIA PHARMA PRIVATE LTDTELMISARTAN USP (NON-STERILE DRUG SUBSTANCE)

DMF 258102012

SHARON BIO MEDICINE LTDTELMISARTAN USP

DMF 261232012

MICRO LABS LTDTELMISARTAN USP

DMF 275382013

ALIVUS LIFE SCIENCES LTDTELMISARTAN USP (D297 PROCESS)

DMF 278042014

IPCA LABORATORIES LTDTELMISARTAN USP

DMF 279462014

TOPHARMAN SHANDONG CO LTDTELMISARTAN

DMF 283092014

HOLIDAY LABS MEXICO SA DE CVTELMISARTAN

DMF 317062017

UNICHEM LABORATORIES LTDTELMISARTAN USP

DMF 326212018

CHROMO LABORATORIES INDIA PRIVATE LTDTELMISARTAN USP

DMF 339892019

MANKIND PHARMA LTDTELMISARTAN USP

DMF 368072022

GLOCHEM INDUSTRIES PRIVATE LTDTELMISARTAN

DMF 387722023

VASUDHA PHARMA CHEM LTDTELMISARTAN USP

DMF 388402023

KP MANISH GLOBAL INGREDIENTS PVT LTDTELMISARTAN USP

DMF 398212024

CTX LIFESCIENCES PVT LTDTELMISARTAN USP

DMF 399262024

ZHEJIANG JINGSHENG PHARMACEUTICAL CO LTDTELMISARTAN

DMF 417562025

GLENMARK PHARMACEUTICALS LTDInactiveTELMISARTAN

DMF 187592005

DR REDDYS LABORATORIES LTDInactiveTELMISARTAN

DMF 197592006

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveTELMISARTAN

DMF 205712007

GLENMARK LIFE SCIENCES LTDInactiveTELMISARTAN USP

DMF 205752007

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveTELMISARTAN USP (NON-STERILE BULK)

DMF 223522008

CADILA PHARMACEUTICALS LTDInactiveTELMISARTAN

DMF 224432009

SEQUEL PHARMACHEM PRIVATE LTDInactiveTELMISARTAN EP

DMF 227682009

JIANGXI SYNERGY PHARMACEUTICAL CO LTDInactiveTELMISARTAN

DMF 242112010

TORRENT PHARMACEUTICALS LTDInactiveTELMISARTAN

DMF 243622010

IND SWIFT LABORATORIES LTDInactiveTELMISARTAN

DMF 244722011

LUPIN LTDInactiveTELMISARTAN USP

DMF 246382011

COSMA SPAInactiveTELMISARTAN

DMF 247032011

HETERO LABS LTDInactiveTELMISARTAN, USP (FORM A)

DMF 250292011

ZHEJIANG TIANYU PHARMACEUTICAL CO LTDInactiveTELMISARTAN METHYL ESTER

DMF 255522011

SIGNA SA DE CVInactiveTELMISARTAN USP/EP

DMF 257422012

DIVIS LABORATORIES LTDInactiveTELMISARTAN, USP

DMF 260282012

AMOLI ORGANICS PVT LTDInactiveTELMISARTAN USP

DMF 265362012

FDC LTDInactiveTELMISARTAN USP

DMF 318232017

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 20MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: May 3, 2017

No patent or exclusivity listings for this strength.

#002 — 40MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: May 3, 2017

#003 — 80MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: May 3, 2017